BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Almufty HB, Mohammed SA, Abdullah AM, Merza MA. Potential adverse effects of COVID19 vaccines among Iraqi population; a comparison between the three available vaccines in Iraq; a retrospective cross-sectional study. Diabetes Metab Syndr 2021;15:102207. [PMID: 34280733 DOI: 10.1016/j.dsx.2021.102207] [Cited by in Crossref: 31] [Cited by in F6Publishing: 33] [Article Influence: 15.5] [Reference Citation Analysis]
Number Citing Articles
1 Duijster JW, Lieber T, Pacelli S, Van Balveren L, Ruijs LS, Raethke M, Kant A, Van Hunsel F. Sex-disaggregated outcomes of adverse events after COVID-19 vaccination: A Dutch cohort study and review of the literature. Front Immunol 2023;14. [DOI: 10.3389/fimmu.2023.1078736] [Reference Citation Analysis]
2 Meo AS, Masood A, Shabbir U, Ali H, Nadeem Z, Meo SA, Alshahrani AN, AlAnazi S, Al-Masri AA, Al-Khlaiwi T. Adverse Effects of Sinopharm COVID-19 Vaccine among Vaccinated Medical Students and Health Care Workers. Vaccines (Basel) 2023;11. [PMID: 36679950 DOI: 10.3390/vaccines11010105] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Chen P, Shi X, He W, Zhong G, Tang Y, Wang H, Zhang P. mRNA vaccine-a desirable therapeutic strategy for surmounting COVID-19 pandemic. Hum Vaccin Immunother 2022;18:2040330. [PMID: 35321627 DOI: 10.1080/21645515.2022.2040330] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Nassar RI, Barakat M, Thiab S, El-Hajji F, Barqawi H, El-Huneidi W, Basheti IA, Abu-Gharbieh E. Web-Based Reporting of Post-Vaccination Symptoms for Inactivated COVID-19 Vaccines in Jordan: A Cross-Sectional Study. Vaccines (Basel) 2022;11. [PMID: 36679889 DOI: 10.3390/vaccines11010044] [Reference Citation Analysis]
5 Chekol Abebe E, Mengie Ayele T, Tilahun Muche Z, Behaile T/Mariam A, Dagnaw Baye N, Mekonnen Agidew M, Asmamaw Dejenie T. Evaluation and comparison of post-vaccination adverse effects among Janssen and Oxford-AstraZeneca vaccinated adult individuals in Debre Tabor Town: A cross- sectional survey in Northwest Ethiopia. Hum Vaccin Immunother 2022;18:2104059. [PMID: 35960924 DOI: 10.1080/21645515.2022.2104059] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
6 Khaleel SM, Shanshal SA, Aladul MI. Adverse reactions of different COVID-19 vaccines among healthcare professionals: A qualitative study in Mosul, Iraq. Clinical Epidemiology and Global Health 2022;18:101175. [DOI: 10.1016/j.cegh.2022.101175] [Reference Citation Analysis]
7 Almufty HB, Mamani MMA, Ali AH, Merza MA. COVID-19 vaccine breakthrough infection among fully vaccinated healthcare workers in Duhok governorate, Iraqi Kurdistan: A retrospective cohort study. J Med Virol 2022;94:5244-50. [PMID: 35811398 DOI: 10.1002/jmv.27985] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
8 Thonginnetra S, Tawinprai K, Niemsorn K, Promsena P, Tandhansakul M, Kasemlawan N, Ruangkijpaisal N, Banomyong N, Phattraprayoon N, Rangkakulnuwat P, Vanichsetakul P, Ungtrakul T, Wittayasak K, Thonwirak N, Soonklang K, Mahanonda N. Safety after BBIBP-CorV (Sinopharm) COVID-19 Vaccine in Adolescents Aged 10-17 Years in Thailand. Vaccines (Basel) 2022;10. [PMID: 36298630 DOI: 10.3390/vaccines10101765] [Reference Citation Analysis]
9 Liang HY, Wu Y, Yau V, Yin HX, Lowe S, Bentley R, Ahmed MA, Zhao W, Sun C. SARS-CoV-2 Variants, Current Vaccines and Therapeutic Implications for COVID-19. Vaccines (Basel) 2022;10:1538. [PMID: 36146616 DOI: 10.3390/vaccines10091538] [Reference Citation Analysis]
10 Magdy R, Khedr D, Yacoub O, Attia A, Abdelrahman MA, Mekkawy D. Epidemiological aspects of headache after different types of COVID ‐19 vaccines: An online survey. Headache 2022;62:1046-1052. [DOI: 10.1111/head.14374] [Reference Citation Analysis]
11 Farhat M, Al-ibrahim R, Almohammedali A, Aljishi R, Alalwan B. Study of the Side Effects of Pfizer and Oxford COVID-19 Vaccines in the Eastern Province of Saudi Arabia. IJGM 2022;Volume 15:7547-7558. [DOI: 10.2147/ijgm.s379204] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
12 Jaffry M, Mostafa F, Mandava K, Rosario S, Jagarlamudi Y, Jaffry K, Kornitzer J, Jedidi K, Khan H, Souayah N. No significant increase in Guillain-Barré syndrome after COVID-19 vaccination in adults: A vaccine adverse event reporting system study. Vaccine 2022:S0264-410X(22)01025-8. [PMID: 36055875 DOI: 10.1016/j.vaccine.2022.08.038] [Reference Citation Analysis]
13 Vakhrusheva AV, Kudriavtsev AV, Kryuchkov NA, Deev RV, Frolova ME, Blagodatskikh KA, Djonovic M, Nedorubov AA, Odintsova E, Ivanov AV, Romanovskaya-romanko EA, Stukova MA, Isaev AA, Krasilnikov IV. SARS-CoV-2 Subunit Virus-like Vaccine Demonstrates High Safety Profile and Protective Efficacy: Preclinical Study. Vaccines 2022;10:1290. [DOI: 10.3390/vaccines10081290] [Reference Citation Analysis]
14 Rayamajhi S, Rafi MA, Tripathi N, Dongol AS, Pandey M, Rayamajhi S, Bhandari S, Shrestha P, Hasan MT, Hossain MG. Adverse events following immunization with ChAdOx1 nCoV-19 and BBIBP-CorV vaccine: A comparative study among healthcare professionals of Nepal. PLoS ONE 2022;17:e0272729. [DOI: 10.1371/journal.pone.0272729] [Reference Citation Analysis]
15 Singh P, Faisal AR, Shah MH, Saeed A, Younas H, Butt US, Pudasaini S, Pasha AR, Rehman U. Early Side Effects after Administration of the 1st Dose of Oxford-AstraZeneca Vaccine.. [DOI: 10.1101/2022.08.04.22278415] [Reference Citation Analysis]
16 Najjar M, Albuaini S, Fadel M, Group DC, Mohsen F. Covid-19 Vaccination Efficacy, Reported Side Effects, and Hesitancy Among the Syrian Population.. [DOI: 10.21203/rs.3.rs-1927000/v1] [Reference Citation Analysis]
17 Sheher Bano, Amjad F, Haider MW, Khalid M, Jabbar S, Iftikhar K, Alam A, Aslam S. Association of Post Vaccination Shoulder Pain with Sinovac and Astrazeneca COVID-19 Vaccines: A Cross-Sectional Study. PBMJ 2022. [DOI: 10.54393/pbmj.v5i7.597] [Reference Citation Analysis]
18 Copana Olmos R, Guillen Rocha N, Mamani Y, Rodriguez Alvarez G, Ovando Campos A, Camacho Tufiño C. Hybrid Immunity for COVID-19 in Bolivian Healthcare Workers. Cureus 2022. [DOI: 10.7759/cureus.27449] [Reference Citation Analysis]
19 Nassar RI, Alnatour D, Thiab S, Nassar A, El-Hajji F, Basheti IA. Short-term side effects of COVID-19 vaccines: A cross-sectional study in Jordan. Hum Vaccin Immunother 2022;:2082792. [PMID: 35759219 DOI: 10.1080/21645515.2022.2082792] [Reference Citation Analysis]
20 Lounis M, Rais MA, Bencherit D, Aouissi HA, Oudjedi A, Klugarová J, Pokorná A, Klugar M, Riad A. Side Effects of COVID-19 Inactivated Virus vs. Adenoviral Vector Vaccines: Experience of Algerian Healthcare Workers. Front Public Health 2022;10:896343. [PMID: 35651866 DOI: 10.3389/fpubh.2022.896343] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 11.0] [Reference Citation Analysis]
21 Orebi HA, Emara HE, Alhindi AA, Shahin MR, Hegazy AH, Kabbash IA, Saied SM. Perceptions and experiences of COVID-19 vaccines’ side effects among healthcare workers at an Egyptian University Hospital: a cross-sectional study. Trop Med Health 2022;50. [DOI: 10.1186/s41182-022-00427-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
22 Babaee E, Amirkafi A, Tehrani-Banihashemi A, SoleimanvandiAzar N, Eshrati B, Rampisheh Z, Asadi-Aliabadi M, Nojomi M. Adverse effects following COVID-19 vaccination in Iran. BMC Infect Dis 2022;22:476. [PMID: 35585518 DOI: 10.1186/s12879-022-07411-5] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
23 Mohsin M, Mahmud S, Mian AU, Hasan P, Muyeed A, Ali MT, Ahmed FF, Islam A, Rahman MM, Islam M, Rahaman Khan MH, Rahman MS. Side Effects of COVID-19 Vaccines and Perceptions about COVID-19 and Its Vaccines in Bangladesh.. [DOI: 10.1101/2022.01.31.22270172] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
24 Fiolet T, Kherabi Y, MacDonald CJ, Ghosn J, Peiffer-Smadja N. Comparing COVID-19 vaccines for their characteristics, efficacy and effectiveness against SARS-CoV-2 and variants of concern: a narrative review. Clin Microbiol Infect 2022;28:202-21. [PMID: 34715347 DOI: 10.1016/j.cmi.2021.10.005] [Cited by in Crossref: 231] [Cited by in F6Publishing: 221] [Article Influence: 231.0] [Reference Citation Analysis]
25 Attash HM, Al-obaidy LM, Al-qazaz HK. Which Type of the Promising COVID-19 Vaccines Produces Minimal Adverse Effects? A Retrospective Cross-Sectional Study. Vaccines 2022;10:186. [DOI: 10.3390/vaccines10020186] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
26 Alfaleh A, Alkattan A, Radwan N, Elzohri M, Alzaher A, Ibrahim M, Alsalameen E, Alsultan A, Alhabib D, Alshelwah A, Mahmoud N, Sagor K, Alabdulkareem K. Adverse drug reactions from two COVID-19 vaccines reported in Saudi Arabia. Drugs Ther Perspect. [DOI: 10.1007/s40267-022-00893-y] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
27 Jiang Y, Wu Q, Song P, You C. The Variation of SARS-CoV-2 and Advanced Research on Current Vaccines. Front Med 2022;8:806641. [DOI: 10.3389/fmed.2021.806641] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 10.0] [Reference Citation Analysis]
28 Sharma K, Neemawat K, Sharma A. Adverse drug reactions and potential risk factors to Covishield vaccine: A cross-sectional study among dentists of different tertiary care centers. J Oral Res Rev 2022;14:109. [DOI: 10.4103/jorr.jorr_62_21] [Reference Citation Analysis]
29 Klugar M, Riad A, Mohanan L, Pokorná A. COVID-19 Vaccine Booster Hesitancy (VBH) of Healthcare Workers in Czechia: National Cross-Sectional Study. Vaccines (Basel) 2021;9:1437. [PMID: 34960183 DOI: 10.3390/vaccines9121437] [Cited by in Crossref: 33] [Cited by in F6Publishing: 38] [Article Influence: 16.5] [Reference Citation Analysis]
30 Konu YR, Gbeasor-Komlanvi FA, Yerima M, Sadio AJ, Tchankoni MK, Zida-Compaore WIC, Nayo-Apetsianyi J, Afanvi KA, Agoro S, Salou M, Landoh DE, Nyansa AB, Boko E, Mijiyawa M, Ekouevi DK. Prevalence of severe adverse events among health professionals after receiving the first dose of the ChAdOx1 nCoV-19 coronavirus vaccine (Covishield) in Togo, March 2021. Arch Public Health 2021;79:207. [PMID: 34819146 DOI: 10.1186/s13690-021-00741-x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
31 Zahid MN. Unfolding the Mild to Moderate Short-Term Side Effects of Four COVID-19 Vaccines Used in Bahrain: A Cross-Sectional Study. Vaccines (Basel) 2021;9:1369. [PMID: 34835300 DOI: 10.3390/vaccines9111369] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
32 Dziedzic A, Riad A, Attia S, Klugar M, Tanasiewicz M. Self-Reported Adverse Events of COVID-19 Vaccines in Polish Healthcare Workers and Medical Students. Cross-Sectional Study and Pooled Analysis of CoVaST Project Results in Central Europe. J Clin Med 2021;10:5338. [PMID: 34830620 DOI: 10.3390/jcm10225338] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 6.5] [Reference Citation Analysis]
33 Azd-1222. Reactions Weekly 2021;1879:66-66. [DOI: 10.1007/s40278-021-04550-8] [Reference Citation Analysis]
34 Riad A, Hocková B, Kantorová L, Slávik R, Spurná L, Stebel A, Havriľak M, Klugar M. Side Effects of mRNA-Based COVID-19 Vaccine: Nationwide Phase IV Study among Healthcare Workers in Slovakia. Pharmaceuticals (Basel) 2021;14:873. [PMID: 34577573 DOI: 10.3390/ph14090873] [Cited by in Crossref: 36] [Cited by in F6Publishing: 40] [Article Influence: 18.0] [Reference Citation Analysis]